M. Laudenslager

发表

Germline PHOX2B mutation in hereditary neuroblastoma.

E. Rappaport, J. Maris, A. Carlisle, 2004, American journal of human genetics.

Identification of ALK as a major familial neuroblastoma predisposition gene

John M. Maris, Nicholas J. Schork, Ali Torkamani, 2008, Nature.

RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma

Cynthia Winter, Sharon J Diskin, John M Maris, 2011, Proceedings of the National Academy of Sciences.

Copy number variation at 1q21.1 associated with neuroblastoma

Sharon J. Diskin, John M. Maris, Struan F. A. Grant, 2009, Nature.

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.

Nazneen Rahman, Joseph T. Glessner, Hakon Hakonarson, 2008, The New England journal of medicine.

Prevalence and functional consequence of PHOX2B mutations in neuroblastoma

J. Maris, Y. Mossé, N. Wasserman, 2008, Oncogene.

Autonomic nervous system involvement in patients with human immunodeficiency virus infection

Jeffrey A. Cohen, M. Laudenslager, J. Cohen, 1989, Neurology.

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.

Ravi Radhakrishnan, Peter J. Huwe, E. Rappaport, 2014, Cancer cell.

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

Nazneen Rahman, Sharon J. Diskin, John M. Maris, 2009, Nature Genetics.

Abstract 3867: Understanding the neuroblastoma predisposition signal at chromosome 2q35: Identification of the β-BARD1 isoform as an oncogenic driver

K. Cole, E. Rappaport, M. Devoto, 2010 .

Genome-Wide Linkage Analysis to Identify Genetic Modifiers of ALK Mutation Penetrance in Familial Neuroblastoma

H. Hakonarson, M. Devoto, C. Specchia, 2011, Human Heredity.

Letters to the Editor No " Bias " toward the Null Hypothesis in Most Conventional Multipoint Nonparametric Linkage Analyses Comparison of Linkage Statistics Analyses Using All 200 Families and Using Only the 147 Informative Families

E. Rappaport, J. Maris, A. Carlisle, 2004 .

Commercial Weight Loss Programs in the Management of Obesity: an Update

K. Gudzune, M. Laudenslager, Z. Chaudhry, 2021, Current Obesity Reports.

Association between the soluble receptor for advanced glycation end products (sRAGE) and NAFLD in participants in the Atherosclerosis Risk in Communities Study.

J. Pankow, M. Lazo, E. Selvin, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Stratification of patients with neuroblastoma for targeted ALK inhibitor therapy.

E. Rappaport, J. Maris, S. Diskin, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.